Pulike Biological Engineering, Inc. (SHA:603566)

China flag China · Delayed Price · Currency is CNY
14.53
+0.08 (0.55%)
Sep 15, 2025, 2:45 PM CST
0.55%
Market Cap4.96B
Revenue (ttm)1.12B
Net Income (ttm)135.04M
Shares Out341.92M
EPS (ttm)0.40
PE Ratio36.37
Forward PE25.91
Dividend0.40 (2.77%)
Ex-Dividend DateJun 11, 2025
Volume3,151,366
Average Volume6,329,103
Open14.51
Previous Close14.45
Day's Range14.32 - 14.59
52-Week Range10.80 - 15.79
Beta0.36
RSI42.66
Earnings DateAug 29, 2025

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company was founded in 1995 and is headquartered in Luoyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 1,551
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603566
Full Company Profile

Financial Performance

In 2024, SHA:603566's revenue was 1.04 billion, a decrease of -16.77% compared to the previous year's 1.25 billion. Earnings were 92.81 million, a decrease of -46.82%.

Financial Statements

News

There is no news available yet.